Cordyceps Sunshine Biotech Holdings (RAJAF) Non-Current Debt (2020 - 2023)

Cordyceps Sunshine Biotech Holdings' Non-Current Debt history runs 4 years deep, the most recent figure standing at $431079.0 for Q4 2023.

• In Q4 2023, Non-Current Debt rose 4.13% year-over-year to $431079.0; the TTM figure through Dec 2023 stood at $431079.0 (up 4.13% YoY), while the FY2023 annual figure was $431079.0, up 4.13% from the prior year.
• Non-Current Debt was $431079.0 for Q4 2023 at Cordyceps Sunshine Biotech Holdings, up from $414000.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $431079.0 in Q4 2023 to a low of $414000.0 in Q4 2020.
• Historically, Non-Current Debt has averaged $417415.8 across 4 years, with a median of $414000.0 in 2020.
• The sharpest annual moves came in 2021 and 2023: Non-Current Debt changed 0.0% in 2021, then advanced 4.13% in 2023.
• A 4-year view of Non-Current Debt shows it stood at $414000.0 in 2020, then changed by 0.0% to $414000.0 in 2021, then changed by 0.0% to $414000.0 in 2022, then advanced by 4.13% to $431079.0 in 2023.
• The last three Non-Current Debt figures came in at $431079.0 (Q4 2023), $414000.0 (Q3 2023), and $414000.0 (Q4 2022), per Business Quant data.